Efficacy of MET-Targeting CAR T Cells against Glioblastoma Patient-Derived Xenograft Models

Whereas MET inhibitors are effective in MET-active tumors, MET-CAR T cells eradicate MET-positive glioblastoma (GBM) growth in an antigen-dependent manner, demonstrating a promising therapeutic approach for treating MET-positive GBM.